Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Implications for Current Clinical Practice

Speaker(s)

• 

  Mazen Noureddin, MD

  Professor Of Medicine
  Souther California Liver Institute, Texas, United States